GLUE
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. (GLUE) has 12 SEC Form 4 filings (28 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 16, 2026.
The most active filer is Chief Operating Officer Champoux Jennifer with 4 filings. Insiders have net sold $1.9M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Markus Warmuth
- Employees:142
- HQ:Boston, MA, US
- IPO:2021-06-24
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.9M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$2.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Operating Officer | Sale | 4,351 | $102K | Jul 16 | SEC ↗ | |
| Chief Scientific Officer | Sale | 6,000 | $140K | Jul 7 | SEC ↗ | |
| Chief Medical Officer | Sale | 5,407 | $132K | Jul 1 | SEC ↗ | |
| Chief Medical Officer | Sale | 6,000 | $138K | Jun 30 | SEC ↗ | |
Manning Anthony M.First filing | Director | Sale | 10,000 | $231K | Jun 30 | SEC ↗ |
Janku FilipFirst filing | Chief Medical Officer | Sale | 11,845 | $240K | Jun 25 | SEC ↗ |
Janku FilipFirst filing | Chief Medical Officer | Sale | 30,000 | $643K | Jun 25 | SEC ↗ |
| Chief Scientific Officer | Sale | 3,000 | $60K | Jun 25 | SEC ↗ | |
| Chief Operating Officer | Sale | 2,175 | $44K | Jun 25 | SEC ↗ | |
Townson SharonFirst filing | Chief Scientific Officer | Sale | 3,000 | $57K | Jun 18 | SEC ↗ |
| Chief Operating Officer | Sale | 2,176 | $41K | Jun 18 | SEC ↗ | |
Champoux JenniferFirst filing | Chief Operating Officer | Sale | 2,175 | $44K | May 28 | SEC ↗ |
Related companies
Monte Rosa Therapeutics, Inc. is in the Healthcare sector.